The Pharmacoeconomics Research Unit provides high-quality information about the cost-effectiveness of drugs and medical technologies. We apply rigorous, systematic methods in cost-effectiveness analyses to evaluate the use of new or existing health care technologies. Our results support evidence-based decisions about health policy and practice.
CIHR Emerging Team Grant – “CIHR Team in Population-based Colorectal Cancer Screening”: Cost-effectiveness of colorectal cancer screening in Ontario and Alberta (2007–2012)
CIHR Partnerships in Health System Improvement Grant – “Factors Influencing Adoption of New Cancer Drugs within Difference Institutional Contexts” (2007–2010)
Ontario Ministry of Health and Long-Term Care Ontario Research Fund –- “From disease gene mapping to clinical practice – an international program in clinical genomics”: Cost-effectiveness of genetic tests for Alzheimer’s disease, hepatitis C and rheumatoid arthritis in Ontario (2008–2011)
Ontario Ministry of Health and Long-Term Care Ontario Research Fund – “[grant name]”: Cost-effectiveness of intensity-modulated radiation therapy in cancer patients in Ontario (2008–2010)